These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 15467723)
1. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Orabona C; Grohmann U; Belladonna ML; Fallarino F; Vacca C; Bianchi R; Bozza S; Volpi C; Salomon BL; Fioretti MC; Romani L; Puccetti P Nat Immunol; 2004 Nov; 5(11):1134-42. PubMed ID: 15467723 [TBL] [Abstract][Full Text] [Related]
2. CD28/CTLA-4--CD80/CD86 and ICOS--B7RP-1 costimulatory pathway in bronchial asthma. Chen YQ; Shi HZ Allergy; 2006 Jan; 61(1):15-26. PubMed ID: 16364152 [TBL] [Abstract][Full Text] [Related]
3. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A. Mukherjee S; Ahmed A; Nandi D J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440 [TBL] [Abstract][Full Text] [Related]
4. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity. Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138 [TBL] [Abstract][Full Text] [Related]
5. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells. Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772 [TBL] [Abstract][Full Text] [Related]
6. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2. Biburger M; Weth R; Wels WS J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482 [TBL] [Abstract][Full Text] [Related]
7. Time courses of B7 family molecules expressed on activated T-cells and their biological significance. Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113 [TBL] [Abstract][Full Text] [Related]
8. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Chen L Nat Rev Immunol; 2004 May; 4(5):336-47. PubMed ID: 15122199 [No Abstract] [Full Text] [Related]
9. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Chen HW; Liao CH; Ying C; Chang CJ; Lin CM Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844 [TBL] [Abstract][Full Text] [Related]
10. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Baban B; Hansen AM; Chandler PR; Manlapat A; Bingaman A; Kahler DJ; Munn DH; Mellor AL Int Immunol; 2005 Jul; 17(7):909-19. PubMed ID: 15967784 [TBL] [Abstract][Full Text] [Related]
11. Graded function of CD80 and CD86 in initiation of T-cell immune response and cardiac allograft survival. Xiang J; Gu X; Qian S; Chen Z Transpl Int; 2008 Feb; 21(2):163-8. PubMed ID: 17971032 [TBL] [Abstract][Full Text] [Related]
12. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle. Giguère JF; Bounou S; Paquette JS; Madrenas J; Tremblay MJ J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715 [TBL] [Abstract][Full Text] [Related]
13. CD28/CTLA-4 ligands: the gene encoding CD86 (B70/B7.2) maps to the same region as CD80 (B7/B7.1) gene in human chromosome 3q13-q23. Fernández-Ruiz E; Somoza C; Sánchez-Madrid F; Lanier LL Eur J Immunol; 1995 May; 25(5):1453-6. PubMed ID: 7539761 [TBL] [Abstract][Full Text] [Related]
14. Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma. He L; Zhang G; He Y; Zhu H; Zhang H; Feng Z Anticancer Res; 2005; 25(5):3309-13. PubMed ID: 16101143 [TBL] [Abstract][Full Text] [Related]
15. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells. Habib-Agahi M; Phan TT; Searle PF Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894 [TBL] [Abstract][Full Text] [Related]
16. Blockade of CD80 and CD86 at the time of implantation inhibits maternal rejection to the allogeneic fetus in abortion-prone matings. Jin LP; Zhou YH; Wang MY; Zhu XY; Li DJ J Reprod Immunol; 2005 Apr; 65(2):133-46. PubMed ID: 15811518 [TBL] [Abstract][Full Text] [Related]
17. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Jun HX; Jun CY; Yu ZX Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404 [TBL] [Abstract][Full Text] [Related]
18. Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity. Liao KW; Chen BM; Liu TB; Tzou SC; Lin YM; Lin KF; Su CI; Roffler SR Cancer Gene Ther; 2003 Oct; 10(10):779-90. PubMed ID: 14502231 [TBL] [Abstract][Full Text] [Related]
19. CD80 and CD86 expression on LPS-stimulated monocytes and the effect of CD80 and CD86 blockade on IL-4 and IFN-gamma production in nonatopic bronchial asthma. Rutkowski R; Moniuszko T; Stasiak-Barmuta A; Kosztyła-Hojna B; Alifier M; Rutkowski K; Tatarczuk-Krawiel A Arch Immunol Ther Exp (Warsz); 2003; 51(6):421-8. PubMed ID: 14692664 [TBL] [Abstract][Full Text] [Related]
20. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation. Bhattacharyya S; Cowan MJ Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]